|
US2166963A
(en)
*
|
1936-11-19 |
1939-07-25 |
Sharp & Dohme Inc |
Antigenic polysaccharide complex
|
|
GB992132A
(en)
*
|
1961-05-15 |
1965-05-19 |
Parke Davis & Co |
Polysaccharides and methods for their production
|
|
US3269913A
(en)
*
|
1962-05-11 |
1966-08-30 |
Parke Davis & Co |
Staphylococcal-immunizing products and methods for their production
|
|
GB995338A
(en)
|
1963-09-20 |
1965-06-16 |
Parke Davis & Co |
Polysaccharides and methods for their production
|
|
JPS5452794A
(en)
|
1977-09-30 |
1979-04-25 |
Kousaku Yoshida |
Extracting of polysacchride from capusle containing epidermis staphylococus
|
|
US4663160A
(en)
*
|
1983-03-14 |
1987-05-05 |
Miles Laboratories, Inc. |
Vaccines for gram-negative bacteria
|
|
US4808700A
(en)
*
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
|
US5055455A
(en)
*
|
1988-09-28 |
1991-10-08 |
Brigham And Women's Hospital |
Capsular polysaccharide adhesin antigen, preparation, purification and use
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
EP0378881B1
(en)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
FI920131A0
(fi)
|
1989-07-14 |
1992-01-13 |
Praxis Biolog Inc |
Cytokin- och hormonbaerare foer konjugatvaccin.
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
DE69113564T2
(de)
|
1990-08-13 |
1996-05-30 |
American Cyanamid Co |
Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
|
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
|
FR2682388B1
(fr)
*
|
1991-10-10 |
1995-06-09 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
|
|
AU681573B2
(en)
*
|
1991-11-22 |
1997-09-04 |
Glaxosmithkline Biologicals Sa |
Type I and type II surface antigens associated with (staphylococcus epidermidis)
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
US5679654A
(en)
*
|
1994-09-02 |
1997-10-21 |
Brigham & Women's Hospital, Inc. |
Capsular polysaccharide immunomodulator
|
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
US6743430B1
(en)
*
|
1995-03-29 |
2004-06-01 |
Richard E. Parizek |
Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
|
|
DE69615362T3
(de)
|
1995-06-07 |
2006-07-20 |
Smithkline Beecham Biologicals S.A. |
Impfstoff mit einem polysaccharidantigen-trägerprotein-konjugat und einem trägerprotein
|
|
US6294177B1
(en)
*
|
1996-09-11 |
2001-09-25 |
Nabi |
Staphylococcus aureus antigen-containing whole cell vaccine
|
|
US5770208A
(en)
|
1996-09-11 |
1998-06-23 |
Nabi |
Staphylococcus aureus B-linked hexosamine antigen
|
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
|
US6027733A
(en)
|
1997-03-26 |
2000-02-22 |
The Brigham And Women's Hospital, Inc. |
Method for generating saccharide fragments
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
EP1029052B1
(en)
|
1997-11-06 |
2010-08-04 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigens
|
|
ES2278420T3
(es)
|
1997-11-21 |
2007-08-01 |
Serono Genetics Institute S.A. |
Secuencia genomica y polipeptidos de chlamydia pneumoniae, fragmentos de los mismos y uso de los mismos, en particular para diagnostico, prevencion y tratamiento de infeccion.
|
|
CN1280619A
(zh)
|
1997-11-28 |
2001-01-17 |
根瑟特公司 |
沙眼衣原体的基因组序列和多肽,其片段以及其用途,特别是用于诊断、预防和治疗感染
|
|
AU1979599A
(en)
|
1998-01-14 |
1999-08-02 |
Chiron S.P.A. |
(neisseria meningitidis) antigens
|
|
US7018637B2
(en)
|
1998-02-23 |
2006-03-28 |
Aventis Pasteur, Inc |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
|
GB9808932D0
(en)
*
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
|
CN100379757C
(zh)
|
1998-05-01 |
2008-04-09 |
希龙公司 |
脑膜炎奈瑟球菌抗原和组合物
|
|
US7252828B2
(en)
*
|
1998-07-15 |
2007-08-07 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
|
JP2004511201A
(ja)
|
1998-10-09 |
2004-04-15 |
カイロン コーポレイション |
ナイセリアゲノム配列およびそれらの使用方法
|
|
AU1722300A
(en)
|
1998-11-12 |
2000-05-29 |
Regents Of The University Of California, The |
Chlamydia pneumoniae genome sequence
|
|
GB9828000D0
(en)
|
1998-12-18 |
1999-02-10 |
Chiron Spa |
Antigens
|
|
US6146902A
(en)
|
1998-12-29 |
2000-11-14 |
Aventis Pasteur, Inc. |
Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
|
|
US6936258B1
(en)
|
1999-03-19 |
2005-08-30 |
Nabi Biopharmaceuticals |
Staphylococcus antigen and vaccine
|
|
KR100642044B1
(ko)
|
1999-03-19 |
2006-11-10 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
EP1165796A2
(en)
|
1999-04-09 |
2002-01-02 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
US7534866B2
(en)
|
2005-10-19 |
2009-05-19 |
Ibc Pharmaceuticals, Inc. |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
|
|
US6689567B1
(en)
*
|
1999-05-28 |
2004-02-10 |
University Of Guelph |
Method for assaying the function of FlaA1 and WbpM
|
|
CA2871789C
(en)
|
2000-01-17 |
2017-04-04 |
Novartis Vaccines And Diagnostics S.R.L. |
Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
ATE440861T1
(de)
|
2000-07-03 |
2009-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia pneumoniae
|
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
|
AU2002309706A1
(en)
|
2001-05-11 |
2002-11-25 |
Aventis Pasteur, Inc. |
Novel meningitis conjugate vaccine
|
|
US6537577B1
(en)
*
|
2001-06-04 |
2003-03-25 |
Bio Medical Development Corporation |
Method of prophylaxis for bovine mastitis
|
|
GB2379996B
(en)
*
|
2001-06-05 |
2004-05-19 |
Tayside Flow Technologies Ltd |
Flow means
|
|
CN100513548C
(zh)
*
|
2001-06-11 |
2009-07-15 |
应用超微系统股份有限公司 |
将AcmA型蛋白质锚融合体与微生物细胞壁材料进行结合的改良方法
|
|
GB0115176D0
(en)
*
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
US20040161741A1
(en)
|
2001-06-30 |
2004-08-19 |
Elazar Rabani |
Novel compositions and processes for analyte detection, quantification and amplification
|
|
US20030113350A1
(en)
*
|
2001-09-19 |
2003-06-19 |
Fattom Ali I. |
Glycoconjugate vaccines for use in immune-compromised populations
|
|
GB0210128D0
(en)
|
2002-05-02 |
2002-06-12 |
Chiron Spa |
Nucleic acids and proteins from streptococcus groups A & B
|
|
AU2003257003A1
(en)
|
2002-07-30 |
2004-02-16 |
Baxter Healthcare S.A. |
Chimeric multivalent polysaccharide conjugate vaccines
|
|
US20060121058A1
(en)
*
|
2002-08-08 |
2006-06-08 |
Children's Medical Center Corporation |
Anti-pneumococcal preparations
|
|
WO2004018646A2
(en)
|
2002-08-26 |
2004-03-04 |
Chiron Corporation |
Conserved and specific streptococcal genomes
|
|
GB0220198D0
(en)
*
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Modified saccharides,conjugates thereof and their manufacture
|
|
WO2004041157A2
(en)
|
2002-09-13 |
2004-05-21 |
Chiron Corporation |
Group b streptococcus vaccine
|
|
WO2004043407A2
(en)
|
2002-11-12 |
2004-05-27 |
The Brigham And Women's Hospital, Inc. |
Methods and products for treating staphylococcal infections
|
|
PT1565478T
(pt)
*
|
2002-11-12 |
2017-11-14 |
The Brigham And Women`S Hospital Inc |
Vacina de polissacáridos para infeções estafilocócicas
|
|
GB0227346D0
(en)
*
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
US9296795B2
(en)
|
2003-03-07 |
2016-03-29 |
Wyeth Holdings, Llc. |
Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
|
|
PT1601689E
(pt)
|
2003-03-13 |
2008-01-04 |
Glaxosmithkline Biolog Sa |
Processo de purificação para citolisina bacteriana
|
|
CA2530363C
(en)
*
|
2003-06-23 |
2013-05-07 |
Baxter International Inc. |
Carrier proteins for vaccines
|
|
RU2337108C2
(ru)
|
2003-07-24 |
2008-10-27 |
Мерк Энд Ко., Инк. |
Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus
|
|
US20060188515A1
(en)
|
2003-07-24 |
2006-08-24 |
Anderson Annaliesa S |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
US8048432B2
(en)
*
|
2003-08-06 |
2011-11-01 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Polysaccharide-protein conjugate vaccines
|
|
WO2005024038A2
(en)
*
|
2003-09-11 |
2005-03-17 |
Nederlands Vaccininstituut |
Process for producing a capsular polysaccharide for use in conjugate vaccines
|
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
|
JP2007528217A
(ja)
|
2004-02-18 |
2007-10-11 |
メルク エンド カムパニー インコーポレーテッド |
スタヒロコッカス・アウレウスに対する防御免疫応答を誘導するためのポリペプチド
|
|
WO2005086663A2
(en)
|
2004-02-27 |
2005-09-22 |
Merck & Co., Inc. |
Polypeptides for inducing a protective immune response against staphlococcus aureus
|
|
US20050250821A1
(en)
*
|
2004-04-16 |
2005-11-10 |
Vincent Sewalt |
Quaternary ammonium compounds in the treatment of water and as antimicrobial wash
|
|
US7842479B2
(en)
*
|
2004-05-21 |
2010-11-30 |
The Board Of Regents Of The University Of Nebraska |
Methods for altering acetic acid production and enhancing cell death in bacteria
|
|
WO2005115113A2
(en)
|
2004-05-25 |
2005-12-08 |
Merck & Co., Inc. |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
GB0413868D0
(en)
*
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
|
US20070264278A1
(en)
|
2004-09-17 |
2007-11-15 |
Anderson Annaliesa S |
Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
|
|
JP2008513406A
(ja)
|
2004-09-22 |
2008-05-01 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物
|
|
US20060134141A1
(en)
|
2004-12-14 |
2006-06-22 |
Nabi Biopharmaceuticals |
Glycoconjugate vaccines containing peptidoglycan
|
|
AU2006206577B2
(en)
|
2005-01-21 |
2012-03-08 |
Merck Sharp & Dohme Corp. |
Polypeptides for inducing a protective immune response against Staphylococcus aureus
|
|
GB0502096D0
(en)
*
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
|
US20060228368A1
(en)
|
2005-04-07 |
2006-10-12 |
Nabi Biopharmaceuticals |
Method of protecting against staphylococcal infection
|
|
FR2884830A1
(fr)
|
2005-04-25 |
2006-10-27 |
Sanofi Pasteur Sa |
Procede de production de souches de staphylococcus aureus surproductrices
|
|
US9486515B2
(en)
*
|
2005-06-27 |
2016-11-08 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
|
WO2007023386A2
(en)
*
|
2005-08-24 |
2007-03-01 |
Novartis Vaccines And Diagnostics Srl |
Zwitterionization of capsular saccharides
|
|
GB0526038D0
(en)
|
2005-12-21 |
2006-02-01 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
WO2007084856A2
(en)
*
|
2006-01-13 |
2007-07-26 |
Baxter International Inc. |
Method for purifying polysaccharides
|
|
EP1998802A2
(en)
*
|
2006-03-30 |
2008-12-10 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
AR060187A1
(es)
|
2006-03-30 |
2008-05-28 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica
|
|
FR2899110A1
(fr)
*
|
2006-03-31 |
2007-10-05 |
Sanofi Pasteur Sa |
Polysaccharides capsulaires de type 5 et de type 8 des souches surproductrices de staphylococcus aureus
|
|
EP2719397A1
(en)
|
2006-06-12 |
2014-04-16 |
GlaxoSmithKline Biologicals SA |
Use of alpha-toxin for treating and preventing staphylococcus infections
|
|
GB0612854D0
(en)
*
|
2006-06-28 |
2006-08-09 |
Novartis Ag |
Saccharide analysis
|
|
WO2008152447A2
(en)
|
2006-10-30 |
2008-12-18 |
The University Of Western Ontario |
Staphylococcus aureus specific anti-infectives
|
|
EP2094317B1
(en)
*
|
2006-11-08 |
2010-09-15 |
B-K Medical ApS |
Method for multi-step sterilization
|
|
DE102006062398A1
(de)
|
2006-12-20 |
2008-06-26 |
Edi (Experimentelle & Diagnostische Immunologie) Gmbh |
Verfahren zur Erkennung und/oder Charakterisierung zellulärer Aktivitätsmuster, Verwendung von Toll-like-Rezeptor-Liganden (TLR-Liganden) und ein Kit
|
|
GB0700135D0
(en)
*
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
GB0700136D0
(en)
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
|
MX2009012891A
(es)
|
2007-05-31 |
2009-12-10 |
Merck & Co Inc |
Proteinas de union a antigeno dirigidas a staphylococcus aureus orf0657n.
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
AU2008292897B2
(en)
|
2007-08-31 |
2015-01-22 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
|
EP2254592B1
(en)
|
2008-02-28 |
2019-06-05 |
Dako Denmark A/S |
Mhc multimers in borrelia diagnostics and disease
|
|
DK2344523T3
(da)
*
|
2008-09-17 |
2016-04-18 |
Glaxosmithkline Biolog Sa |
Gas-kombinationsvacciner og lægemidler
|
|
WO2010042481A1
(en)
*
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial eap, emp, and/or adsa proteins
|
|
WO2010132833A1
(en)
*
|
2009-05-14 |
2010-11-18 |
The Regents Of The University Of Michigan |
Streptococcus vaccine compositions and methods of using the same
|
|
TWI505834B
(zh)
*
|
2009-06-22 |
2015-11-01 |
Wyeth Llc |
組合物及製備金黃色葡萄球菌血清型５及８莢膜多醣結合物之免疫原性組合物之方法
|
|
BRPI1015567A2
(pt)
*
|
2009-06-22 |
2021-08-31 |
Wyeth Llc |
Composições imunogênicas de antígenos de staphylococcus aureus
|
|
GB0913681D0
(en)
*
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
ES2812523T3
(es)
|
2009-09-30 |
2021-03-17 |
Glaxosmithkline Biologicals Sa |
Conjugación de polisacáridos capsulares de Staphylococcus aureus de tipo 5 y de tipo 8
|
|
MX345967B
(es)
*
|
2009-10-30 |
2017-02-28 |
Novartis Ag |
Purificacion de sacaridos capsulares de staphylococcus aureus tipo 5 y tipo 8.
|
|
US8679812B2
(en)
*
|
2009-12-28 |
2014-03-25 |
Kikkoman Corporation |
Method for extracting Staphylococcus aureus antigen, reagent for extracting Staphylococcus aureus antigen, and method for assessing Staphylococcus aureus
|
|
JP5781542B2
(ja)
*
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原
|
|
EP2588120B1
(en)
*
|
2010-07-02 |
2017-11-15 |
The University of Chicago |
Compositions and methods related to protein a (spa) variants
|
|
GB201310008D0
(en)
*
|
2013-06-05 |
2013-07-17 |
Glaxosmithkline Biolog Sa |
Immunogenic composition for use in therapy
|
|
JP2016540764A
(ja)
|
2013-12-04 |
2016-12-28 |
グリコヴァキシン アーゲー |
大腸菌で合成された糖タンパク質ワクチンによる黄色ブドウ球菌感染の予防
|
|
US9775872B2
(en)
|
2014-08-20 |
2017-10-03 |
Professional Compounding Centers Of America |
Topical pharmaceutical bases for preventing viral diseases
|
|
WO2018217564A1
(en)
*
|
2017-05-22 |
2018-11-29 |
The Children's Medical Center Corporation |
Combined vaccine against mycobacterium tuberculosis
|